MUMBAI, India, Jan. 9 -- Intellectual Property India has published a patent application (202541134627 A) filed by Sree Balaji Dental College And Hospital, Chennai, Tamil Nadu, on Dec. 31, 2025, for 'non-invasive salivary glutamate & opiorphin assay for assessment of symptomatic irreversible pulpitis pain.'
Inventor(s) include Dr. Mathangi. R; Dr. N. Aravindha Babu; and Dr. S. Bhuminathan.
The application for the patent was published on Jan. 9, under issue no. 02/2026.
According to the abstract released by the Intellectual Property India: "The present invention discloses a non-invasive diagnostic method for objectively assessing pain associated with symptomatic irreversible pulpitis in human subjects diagnosed with Type 2 Diabetes Mellitu...